Kanabo Group PLC

Research Kanabo Group PLC (KNB) on Bullrun: market cap GBX 1.39M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is GBX 1.39M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2023GBP 895.00K-GBP 7.99M-GBP 3.05M15.0%-0.01GBP 1.68MGBP 272.00KGBP 7.51M
FY2022GBP 603.00K-GBP 6.87M-GBP 3.93M33.0%-0.02GBP 3.20MGBP 707.00KGBP 12.45M
FY2021GBP 73.00K-GBP 4.55M-GBP 2.11M9.6%-0.01GBP 4.48MGBP 0GBP 5.18M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-24GBX 1.39Mn/an/an/a

About Kanabo Group PLC

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Kanabo Group PLC's market cap?

Kanabo Group PLC's market capitalization is GBX 1.39M.

What does Kanabo Group PLC do?

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain.